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Background/aim: Mild cognitive impairment (MCI) is defined as a pathological stage between ‘healthy aging’ and ‘dementia’. In this
study, cases of MCI were compared with early-stage Alzheimer disease (AD) and age-related cognitive decline (ARCD) in terms of
cognitive profiles in order to find a connection between MCI and AD.
Materials and methods: Patients who were comparable in terms of age and sex and who met the criteria of MCI, ARCD, or early-stage
AD were included in the study retrospectively. Wechsler memory scale, executive function, visuospatial, language, and memory tests
were applied to all subjects. Additionally, all patients completed a mini-mental state examination test, geriatric depression scale, and
activities of daily living scale.
Results: Complex attention tests and long-term memory tests were more impaired in MCI patients when compared with ARCD.
However, there were no significant differences between the MCI and ARCD cases in activities of daily living. Memory and executive
functions were more deteriorated in patients with AD in comparison to MCI.
Conclusion: During the follow-up period of ARCD, impairment in orientation, complex attention, and long-term memory should
suggest the diagnosis of MCI. When personal information and executive functions are affected in MCI, AD should be carefully
considered.
Key words: Dementia, MCI, cognitive tests, forgetfulness

1. Introduction
Mild cognitive impairment (MCI) is a partial decline in
cognitive functions in which activities of daily living are not
affected; it is considered to be a period prior to the development
of dementia (1). Several studies indicated that individuals over
the age of 60 have an increased risk for developing dementia,
at about 1%–2% for each year. However, this rate is 10%–15%
for MCI patients (2). Age-related cognitive decline (ARCD) is
a nonpathological decline in memory associated with normal
aging (3). Early diagnosis and discrimination of MCI from
ARCD is important for the patient’s quality of life. Although
the mini-mental state examination (MMSE) test is successfully
used in the diagnosis of dementia, it may fail to diagnose MCI.
Therefore, there is a need for the use of additional cognitive
tests (4). In this study, the cognitive profile, activities of daily
living (ADL) scale, and depression scores of MCI patients
were compared with early-stage of (Alzheimer disease) AD
and ARCD groups to determine the differences.
2. Materials and methods
A total of 126 subjects were included in the study.
All patients had had routine blood tests, brain scans
* Correspondence: drsahin@gmail.com

(computed tomography or magnetic resonance imaging),
and a cognitive test battery. Subjects who were similar in
age, sex, and educational level were grouped as follows:
38 patients were diagnosed with MCI according to the
Petersen criteria (5), 56 were diagnosed with early-stage
AD, and 32 were diagnosed with ARCD according to
DSM-IV and NINCDS-ADRDA criteria (6). Secondary
dementia and psychiatric diseases were excluded.
2.1. Contents of cognitive tests
2.1.1. Memory
All of the patients completed the following parts of the
Wecshler memory scale (WMS): WMS-1, current and
personal information; WMS-2, orientation; WMS-4, story
tracking; WMS-5, backward and forward digit span; WMS6, short-term and long-term memory. Executive functions
were evaluated with clock drawing, proverb interpretation,
Luria drawings, category fluency, and Stroop test (7,8).
2.1.2. Visuospatial functions
Visuospatial functions were evaluated with Benton facial
recognition, line orientation, and copying. Language
function was evaluated with the Boston naming test (9).

1137

BATUM et al. / Turk J Med Sci
2.1.3. Depression
Depression was evaluated by a geriatric depression scale
(10).
2.1.4. Activities of daily living
Daily life activities were examined with an ADL scale
(11).
2.2. Statistical analysis
For statistical analysis, SPSS 15.0 was used. To compare
the nonparametric variables of the three groups, the
Kruskal–Wallis test and Levene test were used. The
Mann–Whitney U test was used for parametric variables
such as cognitive tests, ADL, and geriatric depression
scores of each group. P < 0.05 was considered statistically
significant.
3. Results
The mean age, female/male ratio, and mean years in
education in the MCI, AD, and ARCD groups were 71.5
± 7 years, 23/15, and 9.6 ± 12.4 years; 74 ± 6 years, 37/19,
and 7.2 ± 5 years; and 70.9 ± 8 years, 19/13, and 8.8 ± 5
years, respectively. There were no statistically differences
in demographic data between the groups (P = 0.17, 0.82,
and 0.09).
When comparing ARCD and MCI cases, there was no
significant difference among the parameters of personal
and current information, forward digit span, short-term
visual memory, and language functions. Although MMSE
scores between the two groups did not differ, tests that
required more attention were found to be significantly
different (Table 1). Several test parameters including
MMSE test and ADL test were significantly different
between patients with early-stage AD and MCI (Table 2).
There were no significant differences in depression scores
among the groups.
Table 1. The comparison of neurocognitive test parameters
between mild cognitive impairment (MCI) and age-related
cognitive decline (ARCD).
Neurocognitive test

MCI
(n = 38)

ARCD*
(n = 32)

P*

Orientation

4.5 ± 0.7

4.8 ± 0.3

0.04

Backward digit span

7 ± 4.2

9.1 ± 4.4

0.03

Verbal long-term memory

12.4 ± 4.7

15.2 ± 4.5

0.008

Proverb interpretation

8.3 ± 1.3

8.9 ± 0.5

0.01

Category fluency

14.1 ± 4.9

17.9 ± 5.4

0.001

Verbal fluency

20.5 ± 13.9 26.7 ± 13.3 0.01

Stroop test

66.2 ± 21.6 54 ± 15

0.007

Visual long-term memory

5.4 ± 3.1

0.01

* P < 0.05.
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7.8 ± 3.8

4. Discussion
MCI, defined in 1999, is a heterogeneous group and has
two subtypes: single-domain and multiple-domain. The
clinical course may vary. A large proportion of patients
progress to AD, while a smaller group develops other
types of dementia. Some MCI patients may remain stable,
or their cognitive decline may be reversible. According
to the Mayo Clinic Alzheimer’s Research Center, the AD
conversion rate is around 10%–15% per year (12). This rate
was announced to be 6%–25% per year by the American
Academy of Neurology (13). The development of cognitive
deficits in AD occurs in three main phases. In the first
stage, memory is affected. During this period, episodic
memory impairment is the prior problem, which is caused
by failure to record new information (14). The learning
of new information is thus reduced. The next step of the
impairment is the effect on daily life. In this early clinical
stage, episodic memory as well as visuospatial perception,
recognition, verbal fluency, and naming are significantly
affected (15,16). Some studies point out that there is no
cognitive difference between MCI patients and healthy
controls (17). However, upon detailed neuropsychological
assessment, MCI patients show learning and memory
impairment compared to nondemented healthy subjects
(18). The examination of long-term memory is especially
suggested as the most important criterion to compare
these groups (19). In our study, long-term memory was
found significantly affected in the MCI group as compared
to the ARCD group. Some studies found attention to be
impaired in MCI (20). Ribeiro et al. also pointed out that
language and verbal fluency are affected as well as memory
and attention in MCI (21). Our study confirms these
results.
Impairment in attention follows memory decline in
AD (22). While simple attention is affected in late stages of
AD, complex attention and distraction are affected in the
early stages (23). Our study also emphasized that although
there was no difference in simple attention between AD
and MCI groups, complex attention parameters such as
backward digit span and story tracking and interference
in Stroop tests were significantly affected in the early-stage
AD group.
In studies of patients with early-stage AD, the most
important criterion is suggested to be delayed recall when
comparing MCI with AD (24,25). In our study, both verbal
and visual delayed recall were found significantly impaired
in the AD group compared to the MCI group.
In studies mentioning executive functions, proverb
interpretation and clock drawing are significantly impaired
in early stages of AD while perseveration is reported in late
stages (23,24,26). In our study, executive functions were
found significantly impaired in the AD group as compared
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Table 2. The comparison of neurocognitive test parameters between Alzheimer
disease (AD) and mild cognitive impairment (MCI).
Neurocognitive test

AD (n = 56)

MCI (n = 38) P*

Personal and current information

3.7 ± 1.4

4.9 ± 1

<0.0001

Orientation

3.2 ± 1.5

4.5 ± 0.7

<0.0001

Backward digit span

5.2 ± 4

7 ± 4.2

0.04

Story tracking

8.4 ± 4.8

13.4 ± 3.8

<0.0001

Long-term memory

6.3 ± 6

12.4 ± 4.7

<0.000

Proverb interpretation

6.8 ± 3.2

8.3 ± 1.3

0.03

Clock drawing

1.1 ± 1.1

1.8 ± 0.9

0.00

Luria drawing

5.2 ± 6

2.3 ± 3.2

0.02

Category fluency

10.9 ± 5.6

14.1 ± 4.9

0.002

Verbal fluency

4.7 ± 2.8

6.1 ± 2.2

0.001

Stroop test

81 ± 39.4

66.2 ± 21.6

0.009

Facial recognition

36.6 ± 8.1

39.9 ± 3.6

0.01

Copying

2.7 ± 1.3

3.3 ± 1

0.01

Short-term visual memory

6.3 ± 3.3

8.5 ± 3.1

0.001

Long-term visual memory

2.6 ± 2.6

5.4 ± 3.1

<0.0001

Mini-mental state examination test

22.5 ± 2.3

26.2 ± 1.2

0.001

Activities of daily living

16.2 ± 2.4

22 ± 1

<0.0001

* P < 0.05.

to the MCI group. Although our group consisted of earlystage AD patients, perseveration was found to be quite
higher than expected.
Our results show that MCI can be neuropsychologically
differentiated from normal aging and dementia. In elderly

populations, the diagnosis of MCI should be established
when complex attention, orientation, and long-term
memory are disturbed. In MCI patients, impairments
in ADL, personal information, and executive functions
should be considered as an indicator of AD.
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